HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

L Zabaglo; O Stoss; J Ruschoff; D Zielinski; J Salter; M Arfi; Ian Bradbury; U Dafni; M Piccart-Gebhart; M Procter; M Dowsett

doi:10.1093/annonc/mdt275

HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

L Zabaglo, O Stoss, J Ruschoff, D Zielinski, J Salter, M Arfi, Ian Bradbury, U Dafni, M Piccart-Gebhart, M Procter, M Dowsett

Research output: Contribution to journal › Article › peer-review

24 Citations (Scopus)

Original language	English
Pages (from-to)	2761-2766
Journal	Annals of Oncology
Volume	24
Issue number	11
DOIs	https://doi.org/10.1093/annonc/mdt275
Publication status	Published (in print/issue) - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdt275

http://annonc.oxfordjournals.org/content/24/11/2761

Cite this

Zabaglo, L., Stoss, O., Ruschoff, J., Zielinski, D., Salter, J., Arfi, M., Bradbury, I., Dafni, U., Piccart-Gebhart, M., Procter, M., & Dowsett, M. (2013). HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab. Annals of Oncology, 24(11), 2761-2766. https://doi.org/10.1093/annonc/mdt275

@article{dd57fa548d0342d7ab904694148a7e25,

title = "HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab",

author = "L Zabaglo and O Stoss and J Ruschoff and D Zielinski and J Salter and M Arfi and Ian Bradbury and U Dafni and M Piccart-Gebhart and M Procter and M Dowsett",

year = "2013",

doi = "10.1093/annonc/mdt275",

language = "English",

volume = "24",

pages = "2761--2766",

journal = "Annals of Oncology",

issn = "1569-8041",

publisher = "Oxford University Press",

number = "11",

}

Zabaglo, L, Stoss, O, Ruschoff, J, Zielinski, D, Salter, J, Arfi, M, Bradbury, I, Dafni, U, Piccart-Gebhart, M, Procter, M & Dowsett, M 2013, 'HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab', Annals of Oncology, vol. 24, no. 11, pp. 2761-2766. https://doi.org/10.1093/annonc/mdt275

TY - JOUR

T1 - HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab

AU - Zabaglo, L

AU - Stoss, O

AU - Ruschoff, J

AU - Zielinski, D

AU - Salter, J

AU - Arfi, M

AU - Bradbury, Ian

AU - Dafni, U

AU - Piccart-Gebhart, M

AU - Procter, M

AU - Dowsett, M

PY - 2013

Y1 - 2013

U2 - 10.1093/annonc/mdt275

DO - 10.1093/annonc/mdt275

M3 - Article

SN - 1569-8041

VL - 24

SP - 2761

EP - 2766

JO - Annals of Oncology

JF - Annals of Oncology

IS - 11

ER -